• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Fundbox Appoints Hilliard Terry to Board of Directors

    6/22/21 12:00:00 PM ET
    $UPST
    $TGH
    $A
    $TLGA
    Finance: Consumer Services
    Finance
    Diversified Commercial Services
    Consumer Discretionary
    Get the next $UPST alert in real time by email

    SAN FRANCISCO, CA, June 22, 2021 (GLOBE NEWSWIRE) -- Fundbox, the financial platform for small businesses, announced today that it has appointed Hilliard Terry to its Board of Directors. Mr. Terry is an experienced executive leader, corporate board member and advisor to private equity backed portfolio companies.  

    Mr. Terry currently serves on the board of directors of Umpqua Holdings Corporation (NASDAQ:UMPQ), a financial services company. He also serves on the board of directors of Upstart Holdings, Inc. (NASDAQ:UPST), a leading artificial intelligence consumer lending platform, and on the board of TLG Acquisition One Corporation (NYSE:TLGA), a special purpose acquisition company.

    "Hilliard is an accomplished public company CFO and a seasoned board member with an impressive record of achievement at the intersection of technology, finance, and banking," said Prashant Fuloria, CEO of Fundbox. "We are thrilled to benefit from his operating and board experience in this time of opportunity and growth post-COVID."

    Mr. Terry has recently served as an advisor to private companies and previously as Executive Vice President and Chief Financial Officer of Textainer (NYSE:TGH). Prior to Textainer, Mr. Terry was Vice President and Treasurer at Agilent Technologies (NYSE:A), and was the Head of Investor Relations during their IPO and subsequent spin-off from Hewlett-Packard. Before joining Agilent, he worked in marketing and investor relations for HP's VeriFone subsidiary. Mr. Terry has also held positions in investor relations and investment banking with Kenetech Corporation and Goldman, Sachs & Co., respectively. He is a qualified financial expert with operating experience and in-depth knowledge of accounting, treasury, investor relations, financial planning & analysis, risk management and corporate development.

    "Through their AI-powered platform, Fundbox is providing access to credit for a much broader community of small businesses, a sector that has been underserved in the past. This is critically important and fundamentally different from anything that has ever been done before," said Mr. Terry. "There is a massive market opportunity ahead and I look forward to rolling up my sleeves and diving into areas like governance and compliance, which are critical fields of investment for a company at this stage." 

    The company is poised for massive growth as the small business economy recovers and expands post-COVID. Recent research has shown that Americans started 4.4 million businesses in 2020, a 24% increase from the year prior, and the first time in history that new businesses have increased during a recession. 

    Fundbox provides access to financial tools that enable small business owners to cover business-critical operating expenses. Their AI technology has enabled the company to scale quickly through automation while increasing access to capital through superior predictions and credit decisions. Fundbox's process is fully automated, and 99% of their decisions are made without human intervention.

    About Fundbox

    Fundbox is a financial platform for small businesses. The company is on a mission to unlock growth for small businesses by providing fast and easy access to financial tools and working capital solutions.  Fundbox has connected with nearly 300,000 businesses, unlocked over $2B in working capital, and invested $100M into its AI platform, gaining deep insights into the small business ecosystem.

    The company has received numerous awards including the prestigious Forbes Best Startup Employers and AI 50, Red Herring Top North American 250, CB Insights Fintech 250, and Fintech Breakthrough Awards. Founded in 2013, Fundbox currently has 200+ employees and offices in San Francisco, CA; Dallas, TX; and Tel Aviv, Israel.



    Liz Berman
    Allison+Partners
    908-566-2090
    liz.berman@allisonpr.com
    
    Get the next $UPST alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $UPST
    $TGH
    $A
    $TLGA

    CompanyDatePrice TargetRatingAnalyst
    Agilent Technologies Inc.
    $A
    7/9/2026$135.00Hold
    Jefferies
    Agilent Technologies Inc.
    $A
    6/26/2026$155.00Outperform
    Bernstein
    Agilent Technologies Inc.
    $A
    6/11/2026$150.00Neutral
    Piper Sandler
    Agilent Technologies Inc.
    $A
    5/28/2026$145.00Neutral → Buy
    BofA Securities
    Agilent Technologies Inc.
    $A
    5/27/2026$153.00Outperform
    RBC Capital Mkts
    Upstart Holdings Inc.
    $UPST
    3/16/2026$43.00Neutral → Buy
    BTIG Research
    Upstart Holdings Inc.
    $UPST
    2/17/2026$30.00Sell → Neutral
    Compass Point
    Upstart Holdings Inc.
    $UPST
    2/13/2026$20.00Mkt Perform → Mkt Underperform
    Citizens
    More analyst ratings

    $UPST
    $TGH
    $A
    $TLGA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Gu Paul bought $1,375,000 worth of shares (50,000 units at $27.50) (SEC Form 4)

    4 - Upstart Holdings, Inc. (0001647639) (Issuer)

    5/14/26 8:24:11 AM ET
    $UPST
    Finance: Consumer Services
    Finance

    Director Girouard Dave bought $4,999,607 worth of shares (170,240 units at $29.37) (SEC Form 4)

    4 - Upstart Holdings, Inc. (0001647639) (Issuer)

    5/8/26 8:54:53 AM ET
    $UPST
    Finance: Consumer Services
    Finance

    Chief Technology Offier Gu Paul bought $3,922,800 worth of shares (100,000 units at $39.23) (SEC Form 4)

    4 - Upstart Holdings, Inc. (0001647639) (Issuer)

    11/13/25 4:31:11 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    $UPST
    $TGH
    $A
    $TLGA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma

    Test enables identification of patients whose tumors express PD-L1 and who may be eligible for treatment with OPDIVO® (nivolumab) or OPDIVO QVANTIG® Agilent Technologies Inc. (NYSE:A) today announced that it has received U.S. Food and Drug Administration (FDA) approval for the PD‑L1 IHC 28‑8 pharmDx assay as a companion diagnostic to identify patients with esophageal squamous cell carcinoma (ESCC), gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma who may be eligible for treatment with OPDIVO® (nivolumab) or OPDIVO QVANTIG® (nivolumab and hyaluronidase‑nvhy), Bristol Myers Squibb’s PD‑1‑targeted immunotherapeutic agents. PD-L1 IHC 28-8 pharmDx is approved for exclusi

    7/14/26 8:00:00 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Upstart Streamlines UMI Reporting

    July 8, 2026 UMI: 1.49 Upstart Holdings, Inc. (NASDAQ:UPST), the leading artificial intelligence (AI) lending marketplace, today announced changes to how and when it publishes its Upstart Macro Index (UMI), along with the latest UMI reading. These changes are intended to make the index easier to interpret. There is no change to how UMI is calculated or used by Upstart.1 How UMI naming and reporting is changing Until today, Upstart introduced one new UMI reading each month, named for the month of loan payments it described. For example, the "May UMI," published on June 25, 2026, reflected the likelihood that Upstart-powered personal loan payments due in May 2026 would eventually be rep

    7/8/26 4:05:00 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis

    Agilent Technologies Inc. (NYSE:A) today announced the latest expansion of its Altura HPLC column portfolio with the introduction of Altura size exclusion chromatography (SEC) and Altura PLRP-S columns, designed to support critical analytical workflows in biopharmaceutical development and production.The new SEC and PLRP-S columns support critical analytical workflows across a range of biotherapeutic modalities, including peptides, proteins, oligonucleotides, and conjugated therapeutics. Applications such as aggregate characterization, molecular weight confirmation and size distribution analysis remain essential for evaluating product quality, stability and performance, while drug-to-antibody

    7/8/26 8:00:00 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $UPST
    $TGH
    $A
    $TLGA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Jefferies resumed coverage on Agilent with a new price target

    Jefferies resumed coverage of Agilent with a rating of Hold and set a new price target of $135.00

    7/9/26 8:26:11 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Bernstein resumed coverage on Agilent with a new price target

    Bernstein resumed coverage of Agilent with a rating of Outperform and set a new price target of $155.00

    6/26/26 9:17:41 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Piper Sandler initiated coverage on Agilent with a new price target

    Piper Sandler initiated coverage of Agilent with a rating of Neutral and set a new price target of $150.00

    6/11/26 8:10:17 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $UPST
    $TGH
    $A
    $TLGA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Senior Vice President Kirkwood Jonah Prevost covered exercise/tax liability with 30 shares, decreasing direct ownership by 0.21% to 14,108 units (SEC Form 4)

    4 - AGILENT TECHNOLOGIES, INC. (0001090872) (Issuer)

    6/29/26 4:03:17 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    New insider Downs Timothy Charles claimed ownership of 8,872 shares (SEC Form 3)

    3 - AGILENT TECHNOLOGIES, INC. (0001090872) (Issuer)

    6/5/26 4:06:09 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    President and CEO Mcdonnell Padraig covered exercise/tax liability with 418 shares, decreasing direct ownership by 0.63% to 65,842 units (SEC Form 4)

    4 - AGILENT TECHNOLOGIES, INC. (0001090872) (Issuer)

    6/5/26 4:03:05 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $UPST
    $TGH
    $A
    $TLGA
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Upstart Holdings Inc.

    SCHEDULE 13G/A - Upstart Holdings, Inc. (0001647639) (Subject)

    7/13/26 5:20:58 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    Agilent Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

    8-K - AGILENT TECHNOLOGIES, INC. (0001090872) (Filer)

    6/25/26 4:23:06 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 10-Q filed by Agilent Technologies Inc.

    10-Q - AGILENT TECHNOLOGIES, INC. (0001090872) (Filer)

    6/1/26 4:09:02 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $UPST
    $TGH
    $A
    $TLGA
    Leadership Updates

    Live Leadership Updates

    View All

    Upstart Appoints Former Santander US CEO Tim Wennes to Its Board of Directors

    Upstart (NASDAQ:UPST), the leading AI lending marketplace, today announced that Tim Wennes has been appointed to the company's Board of Directors, effective May 28, 2026. "Tim brings decades of experience in every flavor of consumer lending, most notably auto," said Paul Gu, CEO of Upstart. "His background is a perfect match for Upstart as we scale towards our ambition of having the best credit product for every segment of American consumers." Wennes brings over 35 years of financial services experience to Upstart. He most recently served as President and CEO of Santander Holdings USA, including Santander Bank N.A., where he oversaw a diversified set of businesses with assets in excess

    5/19/26 9:00:00 AM ET
    $UPST
    Finance: Consumer Services
    Finance

    Agilent Names Michael Buckner as Chief Legal Officer

    Agilent Technologies Inc. (NYSE:A) today announced the appointment of Michael Buckner as chief legal officer, effective today. Buckner brings nearly three decades of experience as a senior global legal executive, with a proven track record of building and leading high-performing teams and deep expertise in complex transactions and regulatory environments. "We are thrilled to welcome Michael to the Agilent team," said Padraig McDonnell, Agilent president and CEO. "His experience leading global legal organizations, combined with his expertise across governance, compliance and regulatory matters, will play a key role as we continue to advance our strategy and deliver for our customers and

    5/4/26 8:00:00 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Agilent Showcases Cancer Research Solutions at AACR 2026

    Agilent Technologies Inc. (NYSE:A) will present new technologies, scientific collaborations, and integrated workflows supporting cancer research and diagnostics at the American Association for Cancer Research (AACR) Annual Meeting on April 17–22, 2026, in San Diego, California. At the meeting, Agilent will highlight advances designed to connect discovery research, translational science, and companion diagnostics development, reflecting the growing demand for more integrated approaches across the cancer research continuum. Among the technologies featured is the BioTek Cytation 9 cell imaging multimode reader, the newest addition to the Cytation series of cell imaging and multimode micropla

    4/15/26 8:00:00 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $UPST
    $TGH
    $A
    $TLGA
    Financials

    Live finance-specific insights

    View All

    Upstart to Announce Second Quarter 2026 Results on August 4, 2026

    Upstart Holdings, Inc. (NASDAQ:UPST), the leading artificial intelligence (AI) lending marketplace, will hold a conference call to discuss its second quarter 2026 financial results on Tuesday, August 4, 2026, at 1:30 p.m. PT / 4:30 p.m. ET. The company’s earnings press release and investor presentation will be available on its investor relations website at ir.upstart.com after the market closes that day. Live webcast. The live webcast and a replay will be available on Upstart’s investor relations website. Conference Call Dial-In. To access the live conference call in the United States and Canada: 800-330-6710, conference code 7744842. To access the live conference call outside of the Un

    7/6/26 5:23:00 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results

    Delivers strong Q2 results and raises FY26 revenue growth, margin expansion, and non-GAAP EPS(4) guidance on continued operational momentum Second-quarter fiscal year 2026 Revenue of $1.83 billion for the second quarter ended April 30, 2026, representing growth of 10.0% reported and up 6.3% core(1) compared with the second quarter of 2025. GAAP operating margin of 21.7%; non-GAAP operating margin(2) of 26.4% expanded by 130 basis points year-over-year and 180 basis points sequentially. GAAP net income of $339 million; earnings per share (EPS) of $1.20, an increase of 60% from the second quarter of 2025. Non-GAAP net income(3) of $423 million; non-GAAP EPS(3) of $1.49, an incre

    5/27/26 4:05:00 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Agilent Announces Cash Dividend of 25.5 Cents per Share

    Agilent Technologies Inc. (NYSE:A) today announced a quarterly dividend of 25.5 cents per share of common stock. The quarterly dividend will be paid on July 22, 2026, to all shareholders of record as of the close of business on June 30, 2026. The timing and amounts of future dividends are subject to the determination and approval of Agilent's board of directors. About Agilent Technologies Agilent Technologies, Inc. (NYSE:A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent's full range of solutions includes instruments, software, services, and expertise that provide tru

    5/20/26 4:27:00 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $UPST
    $TGH
    $A
    $TLGA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Agilent Technologies Inc.

    SC 13G/A - AGILENT TECHNOLOGIES, INC. (0001090872) (Subject)

    11/12/24 1:27:37 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G filed by Agilent Technologies Inc.

    SC 13G - AGILENT TECHNOLOGIES, INC. (0001090872) (Subject)

    11/12/24 11:54:03 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G filed by Agilent Technologies Inc.

    SC 13G - AGILENT TECHNOLOGIES, INC. (0001090872) (Subject)

    11/4/24 10:57:57 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials